A synthetic peptide for use as a blocking control in assays to test for specificity of PEA15 antibody, Alternative Names: PEA15 control peptide, PEA15 antibody Blocking Peptide, Anti-PEA15 Blocking Peptide, Phosphoprotein Enriched In Astrocytes 15 Blocking Peptide, HMAT1 Blocking Peptide, HUMMAT1H Blocking Peptide, MAT1 Blocking Peptide, MAT1H Blocking Peptide, PEA-15 Blocking Peptide, PED Blocking Peptide, PEA15, PEA-15, PEA 15, PEA-15 Blocking Peptide, PEA 15 Blocking Peptide
PEA15
Reaktivität: Human, Maus, Ratte, Affe
Wirt: Synthetic
BP
Applikationshinweise
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
PEA15
(phosphoprotein Enriched in Astrocytes 15 (PEA15))
Synonyme
HMAT1 Peptide, HUMMAT1H Peptide, MAT1 Peptide, MAT1H Peptide, PEA-15 Peptide, PED Peptide, Pea15a Peptide, PEA15 Peptide, DKFZp459O1410 Peptide, proliferation and apoptosis adaptor protein 15 Peptide, phosphoprotein enriched in astrocytes 15 Peptide, proliferation and apoptosis adaptor protein 15 L homeolog Peptide, Astrocytic phosphoprotein PEA-15 Peptide, PEA15 Peptide, Pea15 Peptide, pea15.L Peptide, pea15 Peptide
Hintergrund
PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.PEA15 is a death effector domain (DED)-containing protein predominantly expressed in the central nervous system, particularly in astrocytes.